Is cidofovir a useful adjunctive therapy for recurrent respiratory papillomatosis in children?

International Journal of Pediatric Otorhinolaryngology

Volumn 68, Issue 4, 2004, Pages 413-418

  Shirley, W Peyton ^a   Wiatrak, Brian ^a  

^a CHILDREN S HOSPITAL OF ALABAMA   (United States)

Author keywords

Children; Cidofovir; Interferon; Laryngeal microdebrider; Recurrent respiratory papillomatosis

Indexed keywords

3 INDOLEMETHANOL; CIDOFOVIR; ISOTRETINOIN; METHOTREXATE; RECOMBINANT INTERFERON;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEBRIDEMENT; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; INFANT; MICROLARYNGOSCOPY; MIGRAINE; PAPILLOMATOSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; RECURRENT DISEASE; SCORING SYSTEM; SIDE EFFECT; STANDARD; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; CHILD, PRESCHOOL; CYTOSINE; DEBRIDEMENT; FEMALE; HUMANS; INFANT; INJECTIONS, INTRALESIONAL; LARYNGEAL NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; ORGANOPHOSPHORUS COMPOUNDS; PAPILLOMA; PHOSPHONIC ACIDS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 1542327246     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2003.11.007     Document Type: Article

References (11)

1. Derkay C.S. Task force on recurrent respiratory papillomatosis: a preliminary report. Arch. Otolaryngol. Head Neck Surg. 121(12):1995;1386-1391.
2. Avidano M.A., Singleton G.T. Adjuvant drug strategies in the treatment of recurrent respiratory papillomatosis. Otolaryngol. Head Neck Surg. 112:1995;197-202.
3. Xiong X., Kim C.et al. Kinetic analysis of the interaction of cidofovir disphosphate with human cytomegalovirus DNA polymerase. Biochem. Pharmacol. 48:1994;1986-1988.
4. R. Snoeck, et al., Treatment of severe recurrent laryngeal papillomatosis by local injections of (S)-1-(3-hydroxy-2- phosphonylmethoxypropyl) cytosine (cidofovir), in: Proceedings of the Presentation at Ninth International Conference on Antiviral Research, Urabani, Fukushima, Japan, 19-24 May 1996.
5. Van Cutsem E.et al. Successful treatment of a squamous papillomas of the hypopharynx-esophagus by local injections of (S)-1-(3-hydroxy-2- phosphonylmethoxypropyl) cytosine (cidofovir). J. Med. Virol. 45:1995;230-235.
6. R. Snoeck, et al., Treatment of severe recurrent laryngeal papillomatosis by local injections of (S)-1-(3-hydroxy-2- phosphonylmethoxypropyl) cytosine (cidofovir), in: Proceedings of the Programs and Abstracts of the Ninth International Conference on Antiviral Research Fukushima, Japan, 19-24 May 1996.
7. B.J. Wiatrak, Respiratory papillomatosis, in: G.A. Gates (Ed.), Current Therapy in Otolaryngology - Head and Neck Surgery, sixth ed., Mosby, St. Louis, MO, 1998.
8. Snoeck R.et al. Treatment of severe recurrent laryngeal papillomatosis by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine (cidofovir). J. Med. Virol. 54:1998;219-225.
9. S.M. Pransky, A.E. Magit, D.B. Kearns, D.R. Kang, N.O. Duncan, Intralesional cidofovir of recurrent respiratory papillomatosis, Arch. Otolaryngol. Head Neck Surg. 125 (1999) 1143-1148.
10. S.M. Pransky, D.F. Brewster, A.E. Magit, D.B. Kearns, Clinical update on 10 children treated with intralesional cidofovir injections for severe recurrent respiratory papillomatosis, Arch. Otolaryngol. Head Neck Surg. 126 (2000) 1239-1243.
11. Milczuk H. Intralesional cidofovir for the treatment of severe juvenile recurrent respiratory papillomatosis: long-term results in four children. Otolaryngol. Head Neck Surg. 128(6):2003;788-794.